ResearchMoz

Biotechnology Market By Application (Biopharmacy, Bioservices, Bioagri, Bioindustrial), By Technology (Fermentation, Tissue Regeneration, PCR, Nanobiotechnology, DNA Sequencing & Others) - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2010 - 2017

Transparency Market Research
Published Date » 2013-04-23
No. Of Pages » 115
 
 
   
 The biotechnology market is expected to show substantial growth over the forecast period owing to regulatory support offered to various companies operating in the biotechnology field. In addition, the increased demand for food in developing countries has spurred the growth of the bioagriculture market. Bioseeds are expected to show exponential growth as compared to conventional seeds over the forecast period. 
   
 This report on the biotechnology market analyzes and estimates the global revenue generated by the biotechnology industry over the forecast period i.e. 2012 to 2017. The scope of the report considers biotechnology to be divided into four primary segments namely biopharmacy, bioservices, bioagriculture and bioindustrial. In terms of technology, the biotechnology...
Table of Content

Chapter 1 Preface
1.1 Report Description
1.2 Research Methodology

Chapter 2 Executive Summary

Chapter 3 Market Overview
3.1 Introduction
3.2 Value Chain Analysis
3.3 Market Drivers
3.3.1 Regulatory Support
3.3.2 Increasing Food Demand 
3.3.3 Limited Availability of Non-Renewable Natural Resources
3.4 Market Restraints
3.4.1 Ethical Issues Associated with Clinical Trials
3.4.2 Long Research and Development Lead Time
3.5 Market Opportunities
3.5.1 Emergence of Biosimilars
3.5.2 Biotechnology in Medical Sciences
3.6 Porters Five Force Analysis
3.6.1 Bargaining Power of Suppliers
3.6.2 Bargaining Power of Buyers
3.6.3 Threat of New Entrants
3.6.4 Threat from Substitutes
3.6.5 Degree of Competition
3.7 Biotechnology: Company Market Share Analysis
3.8 Biotechnology: Market Attractiveness Analysis
3.8.1 Biotechnology Market, by Application: Attractiveness Analysis
3.8.2 Biotechnology Market, by Technology: Attractiveness Analysis

Chapter 4 Global Biotechnology Market, by Application
4.1 Global Biotechnology Market: Application Overview
4.1.1 Global Biotechnology Market Revenue Share, by Application, 2010 and 2017
4.2 Biotechnology Market, by Application, 2010 - 2017
4.2.1 Biopharmacy
4.2.1.1 Global Biopharmacy Market, 2010 – 2017 (USD Billion)
4.2.2 Bioservices
4.2.2.1 Global Bioservices Market, 2011 – 2017 (USD Billion)
4.2.3 Bioagriculture
4.2.3.1 Global Bioagriculture Market, 2010 – 2017 (USD Billion)
4.2.4 Bioindustrial
4.2.4.1 Global Bioindustrial Market, 2011 – 2017 (USD Billion)

Chapter 5 Global Biotechnology Market, by Technology
5.1 Global Biotechnology Market Overview, by Technology
5.1.1 Global Biotechnology Market Revenue Share, by Technology, 2010 And 2017
5.2 Fermentation Technology
5.2.1 Global Fermentation Technology Market, 2010 – 2017 (USD Billion)
5.3 Tissue Engineering And Regeneration Technology
5.3.1 Global Tissue Engineering and Regeneration Technology Market, 2010 – 2017 (USD Billion)
5.4 Polymerase Chain Reaction (PCR) Technology
5.4.1 Global PCR Technology Market, 2010 – 2017 (USD Billion)
5.5 Nanobiotechnology
5.5.1 Global Nanobiotechnology Market, 2010 – 2017 (USDBillion)
5.6 Chromatography
5.6.1 Global Chromatography Market, 2010 – 2017 (USD Billion)
5.7 Dna Sequencing Technology
5.7.1 Global DNA Sequencing Technology Market, 2010 – 2017 (USD Billion)
5.8 Cell Based Assay
5.8.1 Global Cell Based Assay Market, 2010 – 2017 (USD Billion)
5.9 Others (Enzyme Technology, Finger Printing, Etc.)
5.9.1 Global Other Technologies Market, 2010 – 2017 (USD Billion)

Chapter 6 Global Biotechnology Market, by Geography
6.1 Global Biotechnology Market Overview, by Geography
6.1.1 Global Biotechnology Market Revenue Share,by Geography, 2011 and 2017
6.2 North America
6.2.1 North America Market for Biotechnology, 2010 – 2017, (USD Billion)
6.2.2 North America Market Demand For Biotechnology, By Application, 2010 – 2017, (USD Billion)
6.2.2.1 Demand for Biopharmacy in North America, 2010 – 2017, (USD Billion)
6.2.2.2 Demand for Bioservices in North America, 2010 – 2017, (USD Billion)
6.2.2.3 Demand for Bioagriculture in North America, 2010 – 2017, (USD Billion)
6.2.2.4 Demand for Bioindustrial Products in North America, 2010 – 2017, (USD Billion)
6.3 Europe
6.3.1 Europe Market for Biotechnology, 2010 – 2017, (USD Billion)
6.3.2 Europe Market Demandfor Biotechnology, by Application, 2010 – 2017, (USD Billion)
6.3.2.1 Demandfor Biopharmacyin Europe, 2010 – 2017, (USD Billion)
6.3.2.2 Demand for Bioservices in Europe, 2010 – 2017, (USD Billion)
6.3.2.3 Demand for Bioagriculture in Europe, 2010 – 2017, (USD Billion)
6.3.2.4 Demand for Bioindustrial Products in Europe, 2010 – 2017, (USD Billion)
6.4 Asia Pacific
6.4.1 Asia Pacific Market for Biotechnology, 2010 – 2017, (USD Billion)
6.4.2 Asia Pacific Market Demandfor Biotechnology, by Application, 2010 – 2017, (USD Billion)
6.4.2.1 Demand for Biopharmacy in Asia Pacific, 2010 – 2017, (USD Billion)
6.4.2.2 Demand For Bioservices in Asia Pacific, 2010 – 2017, (USD Billion)
6.4.2.3 Demand For Bioagriculture in Asia Pacific, 2010 – 2017, (USD Billion)
6.4.2.4 Demand For Bioindustrial Products in Asia Pacific, 2010 – 2017, (USD Billion)
6.5 Rest Of World
6.5.1 Rest of World Market for Biotechnology, 2010 – 2017, (USD Billion)
6.5.2 Rest Of World (Row) Market Demand for Biotechnology, by Application, 2010 – 2017, (USD Billion)
6.5.2.1 Demandfor Biopharmacy in Row, 2010 – 2017, (USDBillion)
6.5.2.2 Demand for Bioservices in Row, 2010 – 2017, (USD Billion)
6.5.2.3 Demand for Bioagriculture in Row, 2010 – 2017, (USD Billion)
6.5.2.4 Demand for Bioindustrial Products in Row, 2010 – 2017, (USD Billion)

Chapter 7 Company Profile
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Overview
7.1.3 Business Strategies
7.1.4 Swot Analysis
7.1.5 Recent Developments
7.2 Amgen Inc.
7.2.1 Company Overview
7.2.2 Financial Overview
7.2.3 Business Strategy
7.2.4 Swot Analysis
7.2.5 Recent Developments
7.3 Glaxosmithkline
7.3.1 Company Overview
7.3.2 Financial Overview
7.3.3 Business Strategy
7.3.4 Swot Analysis
7.3.5 Recent Developments
7.4 Johnson And Johnson
7.4.1 Company Overview
7.4.2 Financial Overview
7.4.3 Business Strategy.
7.4.4 Swot Analysis
7.4.5 Recent Developments
7.5 Merck
7.5.1 Company Overview
7.5.2 Financial Overview
7.5.3 Business Strategy
7.5.4 Swot Analysis
7.5.5 Recent Developments
7.6 Novartis
7.6.1 Company Overview
7.6.2 Financial Overview
7.6.3 Business Strategy
7.6.4 Swot Analysis
7.6.5 Recent Developments
7.7 Novo Nordisk
7.7.1 Company Overview
7.7.2 Financial Overview
7.7.3 Swot Analysis
7.7.4 Business Strategies
7.7.5 Recent Developments
7.8 Pfizer (Wyeth)
7.8.1 Company Overview
7.8.2 Financial Overview
7.8.3 Business Strategies.
7.8.4 Swot Analysis
7.8.5 Recent Developments
7.9 Roche
7.9.1 Company Overview
7.9.2 Financial Overview
7.9.3 Business Strategies
7.9.4 Swot Analysis
7.9.5 Recent Developments
7.10 Sanofi - Aventis
7.10.1 Company Overview
7.10.2 Financial Overview
7.10.3 Business Strategy
7.10.4 Swot Analysis
7.10.5 Recent Developments
7.11 Lonza Group Ltd.
7.11.1 Company Overview
7.11.2 Financial Overview
7.11.3 Business Strategy
7.11.4 Swot Analysis
7.11.5 Recent Developments
7.12 Biogen Idec Inc
7.12.1 Company Overview
7.12.2 Financial Overview
7.12.3 Business Strategy
7.12.4 Swot Analysis
7.12.5 Recent Developments
7.13 Astra Zeneca
7.13.1 Company Overview
7.13.2 Financial Overview
7.13.3 Business Strategy
7.13.4 Swot Analysis
7.13.5 Recent Developments
7.14 Genentech
7.14.1 Company Overview
7.14.2 Financial Overview
7.14.3 Business Strategies
7.14.4 Swot Analysis
7.14.5 Recent Developments
7.15 Genzyme
7.15.1 Company Overview
7.15.2 Financial Overview
7.15.3 Swot Analysis
7.15.4 Recent Developments
7.16 Gilead Sciences
7.16.1 Company Overview
7.16.2 Financial Overview
7.16.3 Swot Analysis
7.16.4 Business Strategies
7.16.5 Recent Developments
7.17 Celgene
7.17.1 Company Overview
7.17.2 Financial Overview
7.17.3 Business Strategy
7.17.4 Swot Analysis
7.17.5 Recent Developments

List of Tables


Table 1 Biotechnology Market: Global Snapshot
Table 2 Drivers For Biotechnology Market: Impact Analysis
Table 3 Restraints For Biotechnology Market : Impact Analysis

List of Figures


Fig. 1 Global Biotechnology Market, 2010 – 2017, (USD Billion)
Fig. 1 Biotechnology Industry: Value Chain Analysis
Fig. 2 World Population Growth, Billion, 2006 - 2012
Fig. 3 Bioseeds Vs. Conventional Seeds Market Demand, USD Million, 2006 - 2011
Fig. 4 Global Crude Oil Price Trend Estimate And Forecast, 2009 – 2018 (USD/Barrel)
Fig. 5 World Biofuel Production, Billion Liters, 2009 - 2018
Fig. 6 Region Split Of Victims Of Lax Clinical Trials, 2011
Fig. 7 Stages Involved In Drug Approval
Fig. 8 Porters Five Forces Analysis
Fig. 9 Biotechnology : Company Market Share, 2011
Fig. 10 Biotechnology Market, By Application: Attractiveness Analysis 2011
Fig. 11 Biotechnology Market, By Application: Attractiveness Analysis, 2011
Fig. 12 Global Biotechnology Market Revenue Share, By Application, 2011 And 2017
Fig. 13 Global Biopharmacy Market, 2010 – 2017 (USD Billion)
Fig. 14 Global Bioservices Market, 2011 – 2017 (USD Billion)
Fig. 15 Global Bioagriculture Market, 2010 – 2017 (USD Billion)
Fig. 16 Global Bioindustrial Market, 2011 – 2017 (USD Billion)
Fig. 17 Global Biotechnology Market Revenue Share, By Technology, 2011 And 2017
Fig. 18 Global Fermentation Technology Market, 2010 – 2017 (USD Billion)
Fig. 19 Global Tissue Engineering And Regeneration Technology Market, 2010 – 2017 (USD Billion)
Fig. 20 Global PCR Technology Market, 2010 – 2017 (USD Billion)
Fig. 21 Global Nanobiotechnology Market, 2010 – 2017 (USD Billion)
Fig. 22 Global Chromatography Market, 2010 – 2017 (USD Billion)
Fig. 23 Global Dna Sequencing Technology Market, 2010 – 2017 (USD Billion)
Fig. 24 Global Cell Based Assay Market, 2010 – 2017 (USD Billion)
Fig. 25 Global Other Technologies Market, 2010 – 2017 (USD Billion)
Fig. 26 Global Biotechnology Market Revenue Share, By Geography, 2011 And 2017
Fig. 27 North America Market For Biotechnology, 2010 – 2017, (USD Billion)
Fig. 28 Demand For Biopharmacy In North America, 2010 – 2017, (USD Billion)
Fig. 29 Demand For Bioservices In North America, 2010 – 2017, (USD Billion)
Fig. 30 Demand For Bioagriculture In North America, 2010 – 2017, (USD Billion)
Fig. 31 Demand For Bioindustrial Products In North America, 2010 – 2017, (USD Billion)
Fig. 32 Europe Market For Biotechnology, 2010 – 2017, (USD Billion)
Fig. 33 Demand For Biopharmacy In Europe, 2010 – 2017, (USD Billion)
Fig. 34 Demand For Bioservices In Europe, 2010 – 2017, (USD Billion)
Fig. 35 Demand For Bioagriculture In Europe, 2010 – 2017, (USD Billion)
Fig. 36 Demand For Bioindustrial Products In Europe, 2010 – 2017, (USD Billion)
Fig. 37 Asia Pacific Market For Biotechnology, 2010 – 2017, (USD Billion)
Fig. 38 Demand For Biopharmacy In Asia Pacific, 2010 – 2017, (USD Billion)
Fig. 39 Demand For Bioservices In Asia Pacific, 2010 – 2017, (USD Billion)
Fig. 40 Demand For Bioagriculture In Asia Pacific, 2010 – 2017, (USD Billion)
Fig. 41 Demand For Bioindustrial Products In Asia Pacific, 2010 – 2017, (USD Billion)
Fig. 42 Rest Of World Market For Biotechnology, 2010 – 2017, (USD Billion)
Fig. 43 Demand For Biopharmacy In Row, 2010 – 2017, (USD Billion)
Fig. 44 Demand For Bioservices In Row, 2010 – 2017, (USD Billion)
Fig. 45 Demand For Bioagriculture In Row, 2010 – 2017, (USD Billion)
Fig. 46 Demand For Bioindustrial Products In Row, 2010 – 2017, (USD Billion)

Upcoming Reports:

Poland: fuel oils market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the fuel oils market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the fuel oils market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview of the main...
Biscuits Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018
By - Transparency Market Research
The market for biscuits is very promising, and expecting a higher growth in near future. Business market is all about effective decision making, and strategic planning as to how to sell, what kind packaging should be done, what will be the pricing strategy etc. Decisions affect the results, whether good or bad, and also affect the competition and the market as a whole. United States and Europe are dominating the world biscuits market.  Asia- pacific region is one of the fastest growing markets. The Biscuits market can be characterized as organized (Big Players) and...
Ultrasound Sensors Market - Global Industry Analysis, Size, Share, Growth, Trends, And Forecast, 2012 - 2018
By - Transparency Market Research
The increasing number of applications in healthcare such as Renal Denervation and Sonography along with the miniaturization of these devices particularly for minimally invasive procedures is predicted to drive the market for these sensors in the coming years. Other drivers are the non-invasive procedures performed by HIFU or High Intensity Focused Ultrasound devices which may not even require contact of the device. Acceptance in medical community particularly with regards to safety and efficacy of ultrasound is expected to be a significant driver for these sensors in the coming years....

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Private Schools Have Higher Male Teaching Staff Than State Schools: Report
Oct 22, 2014  
Private and state education has always been a matter of debate across the UK. A recent study has shown that when it comes to teaching employment options, the difference between state-run and private education in terms of gender balance is absolutely clear.  A report by the Independent Schools Council (ISC) shows that while women dominate both the education medium, the number of...
Abbots First Australian Renewable Energy Deal Rejected
Oct 22, 2014  
The Abbot government’s initial deal for a renewable energy plan has been immediately rejected by the clean energy industry and Labor. The negotiations are about a bipartisan agreement regarding the future of the Australian renewable energy target. The Labor party rejected the first plan as being a job-killer before it was even announced. The plan, they said, would protect solar...
Chemical Production in Europe Flatlines in First Seven Months of 2014
Oct 21, 2014  
The recently published report by European Chemical Industry Council (Cefic) shows overall chemical production in Europe has flatlined in first seven months of this year. Though the initial four months showed a positive trend, the production volumes dropped in July 2014 and in the following months as well. The contraction in output in the three consecutive months has nullified the upward trend...
Actavis to Compete for Omega Pharma
Oct 20, 2014  
Actavic Plc has declared that it will become one of the bidders for the Omega Pharma NV deal, as the United States based drug maker keeps searching for more takeovers. Actavis will be competing against Boehringer Ingelheim GmbH, Sanofi and Perrigi Co. for Omega Pharma. Actavis places themselves as a potential suitor along with quarry in a multitude of potential pharma combinations....
Sale of iPhone Fuels UKs s
Oct 20, 2014  
With the sale of Apple Inc.’s latest smartphone, consumer expenditure on electronics has registered a three-year high this September. The new iPhone 6 and iPhone 6 Plus were launched in the U.K. on September 19 and buyers from across the country raced to purchase the newest smartphone. Both these smartphones are so far the fastest selling Apple products with a sale of over 10 million...